HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric mice

HBsAg-CAR T cells have anti-HBV activity in an authentic preclinical HBV infection model. Our results warrant further preclinical exploration of HBsAg-CAR T cells as immunotherapy for HBV.